Feasibility and acceptance of simultaneous amyloid PET/MRI.
about
Magnetic resonance imaging and positron emission tomography in the diagnosis of neurodegenerative dementias.Biomarkers, designs, and interpretations of resting-state fMRI in translational pharmacological research: A review of state-of-the-Art, challenges, and opportunities for studying brain chemistry.
P2860
Feasibility and acceptance of simultaneous amyloid PET/MRI.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Feasibility and acceptance of simultaneous amyloid PET/MRI.
@en
Feasibility and acceptance of simultaneous amyloid PET/MRI.
@nl
type
label
Feasibility and acceptance of simultaneous amyloid PET/MRI.
@en
Feasibility and acceptance of simultaneous amyloid PET/MRI.
@nl
prefLabel
Feasibility and acceptance of simultaneous amyloid PET/MRI.
@en
Feasibility and acceptance of simultaneous amyloid PET/MRI.
@nl
P2093
P2860
P50
P1476
Feasibility and acceptance of simultaneous amyloid PET/MRI.
@en
P2093
Bernhard Sattler
Dominik Fritzsch
Donald Lobsien
Dorothee Saur
Henryk Barthel
Hermann-Josef Gertz
Joseph Claßen
Jörg Berrouschot
Lisa Schütz
Marianne Patt
P2860
P2888
P304
P356
10.1007/S00259-016-3462-X
P577
2016-07-19T00:00:00Z